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ABSTRACT
Objective: This study was conducted to investigate the effect of extract of Syzygium cumini on serum uric acid levels of rats induced by potassium 
oxonate.
Methods: A total of 30 male Wistar rats were randomly divided into six groups, consist of one normal group (without treatment) and five groups that were 
induced by potassium oxonate 250 mg/kg bw intraperitoneally for 7 days. The ethanol extract of S. cumini leaves dose (100, 200, and 400 mg/kg bw) was 
administered orally 1 h after the potassium oxonate exposure during 7 days. On day 8, blood samples were collected for serum uric acid determination.
Result: Ethanol extract of S. cumini leaves at doses of 100 mg/kg bw, 200 mg/kg bw, and 400 mg/kg bw significantly reduced serum uric acid as 
compared to negative control group of carboxymethylcellulose 0.5%.
Conclusion: Ethanol extract of S. cumini leaves can be used as antihyperuricemic agent.
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INTRODUCTION
Uric acid is the final metabolite of the purine catabolic pathway in 
humans. Hyperuricemia is a state of high uric acid levels; hyperuricemia 
occurs due to excessive production of uric acid or low excretion of 
the acid, abnormal amounts of uric acid in the body, resulting in 
the deposition of urate crystals in the joints and kidneys, causing 
inflammation as well as gouty arthritis and has been linked to renal 
dysfunction [1]. Epidemiological studies showed that more than 20% 
of the world’s population suffered from gout [2].
Gout can be treated using synthetic or natural medicine. Uricosurics 
and uricostatics are the synthetic drugs commonly used to treat gout. 
Uricosuric drugs work by inhibiting the reabsorption of uric acid in the 
kidney tubules so the excretion of uric acid through the kidneys can be 
improved [3]. Uricostatics such as allopurinol is one of the most widely used 
synthetic medicines to inhibit the synthesis of uric acid. However, the use 
of allopurinol is accompanied by side effects such as allergic reactions [4]. 
Besides treatment with synthetic medicines, alternative measures using 
agents derived from plants may also be considered in helping to lower uric 
acid levels. This can be done while putting an effort to reduce side effects of 
synthetic medicines. The ability of the extract in reducing the concentration 
of uric acid is suspected due to the content of the flavonoid compound. 
Flavonoids are widely found in fruits and vegetables. One species of plant 
that is expected to contain flavonoid is Syzygium cumini [5].
Based on research that has been conducted, S. cumini leaves have three 
active flavonoid compounds which were quercetin, myricetin, and 
kaempferol [6]. Quercetin and myricetin are xanthine oxidase inhibitors 
and have free radical dampening activity; kaempferol is a xanthine 
oxidase inhibitor [7]. The purpose of this study was to investigate the 
effect of ethanol extract of S. cumini leaves on serum uric acid levels in 
rats which induced by potassium oxonate.
MATERIALS AND METHODS
Materials
The materials used in this study were potassium oxonate (Sigma-
Aldrich), 0.9% saline (Widatra Bhakti), ethanol 96% (technical), 
and allopurinol (Kimia Farma), the reagent used was from analytical 
grades.
Plant material
S. cumini leaves were collected from Meuraksa, Aceh, Indonesia. The 
plant materials were identified by LIPI Bogor.
Preparation of extracts
S. cumini leaves were washed well, the leaves were dried at room 
temperature and coarsely powdered. The powder was extracted with 
ethanol 96% using cold percolation method.
Antihyperuricemic activity
A total of 30 male rats weighing ±170 g were used for this study. 
The rats were allowed to adapt to their environment at a constant 
temperature for a week before being used. They were given free access 
to feed standard pellets and water during the study. The use of animals 
in this study was approved by the Animal Research Ethics Committee 
Chairman, Faculty of Mathematics and Natural Sciences, Universitas of 
Sumatera Utara.
Rats were divided into six groups containing five animals in each.
•	 Group	I:	Rats	were	induced	by	potassium	oxonate	(250	mg/kg	bw)	
intraperitoneally, after 1 h, rats were administered orally of ethanol 
extract of jamblang leaves at dose of 100 mg/kg bw.
•	 Group	II:	Rats	were	induced	by	potassium	oxonate	(250	mg/kg	bw)	
intraperitoneally, after 1 h, rats were administered ethanol extract 
of jamblang leaves at dose of 200 mg/kg bw.
•	 Group	III:	Rats	were	induced	by	potassium	oxonate	(250	mg/kg	bw)	
intraperitoneally, after 1 h, rats were administered orally of ethanol 
extract of jamblang leaves at dose of 400 mg/kg bw.
•	 Group	IV:	Rats	were	induced	by	potassium	oxonate	(250	mg/kg	bw)	
intraperitoneally, after 1 h, rats were administered orally suspension 
of allopurinol (10 mg/kg bw).
•	 Group	V:	Normal	group	(without	treatment).
•	 Group	 VI : 	 Rats 	 were 	 induced	 by 	 potass ium	 oxonate	
(250 mg/kg bw) intraperitoneally, after 1 h, rats were administered 
orally of carboxymethylcellulose (CMC) 0.5%.
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Each group was administered orally for 7 days. On the 8th day, rats were 
sacrificed by cervical dislocation for blood collection for serum uric 
acid measurement. Blood was collected by venous cava caudal. Serum 
uric acid level was measured by autoanalyzer (Cobas integra).
Statistical analysis
The statistically significant of difference was calculated by the analysis of 
variance followed by Tukey post hoc test. Statistically significant was set 
at p<0.05. The results were expressed as the mean ± SEM of each group.
RESULT
Potassium oxonate caused hyperuricemia in rats, as indicated by 
drastic increases in the serum uric acid levels in negative if control 
group. Serum uric acid of all groups is shown in Table 1.
Administration of the uricase inhibitor, potassium oxonate 250 mg/kg bw 
resulted in hyperuricemic in rats, as indicated by an increase in the serum 
uric	acid	levels	negative	control	group	(Group	VI)	when	compared	to	the	
normal	control	group	(Group	V),	proving	that	allopurinol	may	decrease	
uric acid levels induced by potassium oxonate. Treatment with ethanol 
extract of S. cumini leaves (I-III) significantly (p<0.05) reduced the serum 
urate	levels	when	compared	with	the	negative	control	group	(Group	VI).	
The standard drug allopurinol at dose of 10 mg/kg bw significantly 
(p<0.05) reduction of serum urate level compared to negative control 
group	(Group	VI).	Ethanol	extract	of	S. cumini leaves dose 400 mg/kg bw 
was not significantly different of serum uric acid compared with control 
normal group (p>0.05) and control positive group (p>0.05).
All treatment groups were significantly different from the negative 
control group. The negative control group was the groups which were 
induced with potassium oxonate 250 mg/kg bw until the rats had 
hyperuricemia. The percentage of uric acid in rats which compared to 
negative control group could be seen in Fig. 1.
The ethanol extract of S. cumini leaves has the ability to decrease uric 
acid, but it has lower efficacy compared to allopurinol. This is possible 
because allopurinol is a synthetic drug widely used for hyperuricemia. 
The results showed that ethanol extract of S. cumini leaves could be 
used as a candidate of the traditional uric acid drug.
DISCUSSION
Uric acid is the end metabolite from purine compounds (xanthine) which 
catalyzed by xanthine oxidase. This enzyme plays an important role in 
catalyzing the conversion of hypoxanthine into xanthine, then processed into 
uric acid. Hyperuricemia is an excess of uric acid in the blood [8]. Potassium 
oxonate causes hyperuricemic in rats by inhibiting the uricase activity, if the 
enzyme is inhibited, uric acid will accumulate in rats; therefore, elevation 
of uric acid seems to result from the inhibition of uric acid metabolism [9].
Allopurinol significantly prevented that elevation (Table 1). Allopurinol 
reduces uric acid by inhibiting xanthine oxidase which is an enzyme 
that plays a role in the formation of uric acid; xanthine oxidase is an 
essential target for pharmacology intervention in hyperuricemic or 
gout patients [10]. Allopurinol can also shrink the size of tophi so easily 
remove it from the body [9].
S. cumini leaves have two active flavonoid compounds that lower uric 
acid levels are quercetin and kaempferol [11]. The mechanism of action 
of the kaempferol inhibits xanthine oxidase by the inhibitory effects of 
them on xanthine oxidase activity [12]. Quercetin regulates renal organic 
ion transporters and uromodulin which play the important roles in renal 
urate excretion so that only a few uric acid is reabsorbed [13]. Based on 
above, so that the ethanol extract of S. cumini leaves can be used effectively 
as antihyperuricemic with an effective dose was 400 mg/kg bw.
CONCLUSION
The results of this study demonstrated the ethanol extract of S. cumini 
leaves can reduced serum uric acid level in oxonate-induced rats with 
an effective dose were 400 mg/kg bw.
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